These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28900035)

  • 1. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
    Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
    J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
    Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
    Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
    Nagabhushana A; Bansal M; Swarup G
    PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor α Reduces SNAP29 Dependent Autolysosome Formation to Increase Prion Protein Level and Promote Tumor Cell Migration.
    Li H; Wang R; Yu Z; Shi R; Zhang J; Gao S; Shao M; Cui S; Gao Z; Xu J; Sy MS; Li C
    Virol Sin; 2021 Jun; 36(3):458-475. PubMed ID: 33237393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
    Moquin DM; McQuade T; Chan FK
    PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells.
    Gao L; Tang W; Ding Z; Wang D; Qi X; Wu H; Guo J
    Mol Med; 2015 Feb; 21(1):154-66. PubMed ID: 25715336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
    Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
    Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermidine activates RIP1 deubiquitination to inhibit TNF-α-induced NF-κB/p65 signaling pathway in osteoarthritis.
    Chen Z; Lin CX; Song B; Li CC; Qiu JX; Li SX; Lin SP; Luo WQ; Fu Y; Fang GB; Wei-Ping L; Saw PE; Ding Y
    Cell Death Dis; 2020 Jul; 11(7):503. PubMed ID: 32632306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
    Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
    J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
    Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
    Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB.
    Zhang L; Blackwell K; Shi Z; Habelhah H
    J Mol Biol; 2010 Feb; 396(3):528-39. PubMed ID: 20064526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.
    Xu G; Tan X; Wang H; Sun W; Shi Y; Burlingame S; Gu X; Cao G; Zhang T; Qin J; Yang J
    J Biol Chem; 2010 Jan; 285(2):969-78. PubMed ID: 19910467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
    Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
    Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
    Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
    J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of JNK signaling by the tumor suppressor CYLD.
    Reiley W; Zhang M; Sun SC
    J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.